Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;145(2):137-42.
doi: 10.1001/archsurg.2009.271.

Predictors of occult nodal metastasis in patients with thin melanoma

Affiliations

Predictors of occult nodal metastasis in patients with thin melanoma

Mark B Faries et al. Arch Surg. 2010 Feb.

Abstract

Hypothesis: Thin primary lesions are largely responsible for the rapid increase in melanoma incidence, making identification of appropriate candidates for nodal staging in this group critically important. We hypothesized that common clinical variables may accurately estimate the risk of nodal metastasis after wide excision and determine the need for sentinel node biopsy.

Design: Review of prospectively acquired data in a large melanoma database.

Setting: A tertiary referral center.

Patients: A total of 2211 patients with thin melanoma treated by wide local excision alone were identified in the database between January 1, 1971, and December 31, 2005. Of those, 1732 met entry criteria.

Main outcome measures: We examined the rate of regional nodal recurrence and the impact of clinical and demographic variables by univariate and multivariate analyses.

Results: The overall nodal recurrence rate was 2.9%; median time to recurrence was 38.3 months. Univariate analysis of 1732 patients identified male sex (P < .001), increased Breslow thickness (P < .001), and increased Clark level (P < .001) as significant for nodal recurrence. Multivariate analysis identified male sex (hazard ratio, 3.5; 95% confidence interval, 1.8-7.0; P < .001), younger age (0.45; 0.24-0.86; P = .001), and increased Breslow thickness (2.5; 1.6-3.7; categorical P < .001) as significant for nodal recurrence. The Clark level was no longer significant (P = .63). Breslow thickness, age, and sex were used to develop a scoring system and nomogram for the risk of nodal involvement. Predictions ranged from 0.1% in the lowest-risk group to 17.4% in the highest-risk group.

Conclusions: Many patients with thin melanoma will have nodal recurrence after wide excision alone. Three simple clinical variables may be used to estimate recurrence risk and select patients for sentinel node biopsy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency of regional nodal recurrence by several clinical and pathologic factors: A) Breslow thickness, B) age, C) Clark level, D) sex, E) ulceration, F) primary melanoma site.
Figure 2
Figure 2
Regional nodal metastasis-free survival. Kaplan-Meier plot based on Breslow categories: (0.01–0.25 [n=151], 0.26–0.50 [n=830], 0.51–0.75 [n=515], and 0.76–0.99 [n=236]. Logrank p<0.01 for overall comparison and for comparison of all <0.5 vs. 0.51–0.75 vs. 0.76–0.99.
Figure 3
Figure 3
Nomogram predicting regional nodal recurrence in thin melanoma. Points are assigned based upon patient and tumor characteristics. The total number of points is then used to determine the risk of nodal recurrence using the second plot. c-index =0.791.

Similar articles

Cited by

References

    1. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93:678–683. - PubMed
    1. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer. 2003;98:1223–1231. - PubMed
    1. Gimotty PA, Guerry D, Ming ME, et al. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol. 2004;22:3668–3676. - PubMed
    1. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–1317. - PubMed
    1. Wright BE, Scheri RP, Ye X, et al. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg. 2008;143:892–899. discussion 899–900. - PMC - PubMed

Publication types

MeSH terms